
Both phospholipase D1 (PLD1) and PLD2 regulate degranulation when RBL-2H3 cells are stimulated via the immunoglobulin E receptor, Fc epsilon RI. However, the activation mechanism for PLD2 is unclear. As reported here, PLD2 but not PLD1 is phosphorylated through the Src kinases, Fyn and Fgr, and this phosphorylation appears to regulate PLD2 activation and degranulation. For example, only hemagglutinin-tagged PLD2 was tyrosine phosphorylated in antigen-stimulated cells that had been made to express HA-PLD1 and HA-PLD2. This phosphorylation was blocked by a Src kinase inhibitor or by small interfering RNAs directed against Fyn and Fgr and was enhanced by overexpression of Fyn and Fgr but not by other Src kinases. The phosphorylation and activity of PLD2 were further enhanced by the tyrosine phosphatase inhibitor, Na(3)VO(4). Mutation of PLD2 at tyrosines 11, 14, 165, or 470 partially impaired, and mutation of all tyrosines blocked, PLD2 phosphorylation and activation, although two of these mutations were detrimental to PLD2 function. PLD2 phosphorylation preceded degranulation, both events were equally sensitive to inhibition of Src kinase activity, and both were enhanced by coexpression of PLD2 and the Src kinases. The findings provide the first description of a mechanism for activation of PLD2 in a physiological setting and of a role for Fgr in Fc epsilon RI-mediated signaling.
Small Interfering/metabolism, 610, Proto-Oncogene Proteins c-fyn, Cell Line, Tyrosine/metabolism*, IgE/immunology, Proto-Oncogene Proteins, Receptors, Phospholipase D, Animals, Humans, Point Mutation, Phospholipase D/genetics, Mast Cells, Mast Cells/physiology*, Proto-Oncogene Proteins/metabolism*, Enzyme Inhibitors, Phosphorylation, RNA, Small Interfering, Mast Cells/cytology, src-Family Kinases/genetics, Receptors, IgE, Vanadates/chemistry, Phospholipase D/metabolism*, Enzyme Inhibitors/metabolism, src-Family Kinases/metabolism*, Rats, Enzyme Activation, Proto-Oncogene Proteins/genetics, Pyrimidines, src-Family Kinases, Small Interfering/genetics, Pyrimidines/metabolism, RNA, Tyrosine, Mast Cells/immunology, Vanadates/metabolism, Vanadates
Small Interfering/metabolism, 610, Proto-Oncogene Proteins c-fyn, Cell Line, Tyrosine/metabolism*, IgE/immunology, Proto-Oncogene Proteins, Receptors, Phospholipase D, Animals, Humans, Point Mutation, Phospholipase D/genetics, Mast Cells, Mast Cells/physiology*, Proto-Oncogene Proteins/metabolism*, Enzyme Inhibitors, Phosphorylation, RNA, Small Interfering, Mast Cells/cytology, src-Family Kinases/genetics, Receptors, IgE, Vanadates/chemistry, Phospholipase D/metabolism*, Enzyme Inhibitors/metabolism, src-Family Kinases/metabolism*, Rats, Enzyme Activation, Proto-Oncogene Proteins/genetics, Pyrimidines, src-Family Kinases, Small Interfering/genetics, Pyrimidines/metabolism, RNA, Tyrosine, Mast Cells/immunology, Vanadates/metabolism, Vanadates
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 39 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
